Apellis Pharmaceuticals, Inc. (APLS)

19.77 -0.39 (-1.93%) USD  |  NASDAQ  |  Mar 04, 11:27
More

Apellis Pharmaceuticals EPS Diluted from Other Gain/Loss (Quarterly)

EPS Diluted from Other Gain/Loss (Quarterly) Chart

View EPS Diluted from Other Gain/Loss (Quarterly) for APLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted from Other Gain/Loss (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted from Other Gain/Loss (Quarterly) Range, Past 5 Years

View EPS Diluted from Other Gain/Loss (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted from Other Gain/Loss (Quarterly) Benchmarks

View EPS Diluted from Other Gain/Loss (Quarterly) Benchmarks
Start Trial
Ultragenyx Pharmaceutical, Inc. --
Amneal Pharmaceuticals, Inc. --
Alnylam Pharmaceuticals, Inc. --
BioMarin Pharmaceutical, Inc. --
Amicus Therapeutics, Inc. --